Načítá se...
Urinary protein biomarkers of kidney injury in patients receiving cisplatin chemotherapy
Despite recent progress in the development of novel approaches to treat cancer, traditional antineoplastic drugs, such as cisplatin, remain a mainstay of regimens targeting solid tumors. Use of cisplatin is limited by acute kidney injury, which occurs in approximately 30% of patients. Current clinic...
Uloženo v:
| Vydáno v: | Exp Biol Med (Maywood) |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5813872/ https://ncbi.nlm.nih.gov/pubmed/29231123 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1535370217745302 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|